Clinical Trials Logo

Filter by:
NCT ID: NCT05001841 Completed - Cystic Fibrosis Clinical Trials

Renal Failure Following Lung Transplantation in Cystic Fibrosis Patients

AKI_LUTX
Start date: January 1, 2013
Phase:
Study type: Observational

With this retrospective observational cohort study, we performed a longitudinal assessment of the renal function of the adult CF patients who underwent LUTX, aiming 1) to describe possible risk factors associated with perioperative AKI and 2) to describe AKI short and long term effects on clinical outcomes.

NCT ID: NCT05001139 Completed - Dermatitis Clinical Trials

Clinical Investigation on the Efficacy and Safety of Relizema Ecofoam

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

The scope of this open label clinical trial is to evaluate and confirm the performance of Relizema ecofoam in the improvement of the dermatitis severity. The disease severity will be clinically measured through the Investigator Global Assessment (IGA) after 28 days of treatment.

NCT ID: NCT05001100 Completed - Hip Disease Clinical Trials

A Rehabilitation With Virtual Reality in Patients After Hip Arthroplasty Surgery (VRRS2018)

VRRS2018
Start date: January 20, 2019
Phase: N/A
Study type: Interventional

.Assessing efficacy of rehabilitation with virtual reality exercises compared to traditional rehabilitation in the patient's operated hip arthroplasty

NCT ID: NCT04999280 Completed - Healthy Clinical Trials

Fiber-enriched Croissant Consumption and Effects on Metabolic Status, Appetite and Gut Microbiota

CROMA
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the effect of a daily consumption for 2 weeks of a sourdough croissant enriched with dietary fibers vs a control sourdough croissant with no fiber added on daily energy intakes, fasting metabolic parameters, inflammatory status, blood pressure, anthropometric measures, body composition, appetite sensations, gastrointestinal functionality and gut microbiota composition.

NCT ID: NCT04997980 Completed - Clinical trials for Out-Of-Hospital Cardiac Arrest

AMSA and Amiodarone Study in Cardiac Arrest

MOSAIC
Start date: January 1, 2015
Phase:
Study type: Observational

Investigators' aim is to assess whether the administration of amiodarone during resuscitation could cause a reduction of the values of the amplitude spectral area (AMSA). Amiodarone is recommended for the treatment of cardiac arrest due to ventricular tachycardia/ventricular fibrillation (VT/VF) ( with a low level of recommendation cause of conflicting results. AMSA is a parameter expressing the amplitude of VF and it has been shown to predict defibrillation success and the return of spontaneous circulation (ROSC). No data are available so far about the impact of amiodarone administration on AMSA values.

NCT ID: NCT04996394 Completed - ARDS Clinical Trials

"Effects of Neuromuscular Blocking Agents on End Expiratory Lung Volume During Moderate-severe ARDS"

EIT_CURARO
Start date: December 12, 2019
Phase:
Study type: Observational

This is a monocentric, prospective, observational study that will be conducted in the general ICU of San Gerardo Hospital (Monza, Italy). Study protocol will be started when NMBAs infusion will be stopped for clinical reason until regain of spontaneous breathing activity. Patients will be enrolled at the moment of NMBAs infusion interruption ("baseline" phase). Clinical data will be collected: hemodynamics, ventilation parameters and respiratory mechanics, arterial blood gas analysis, drugs used for sedation and their dosages. An EIT belt will be positioned around the patient's chest when clinical signs of spontaneous breathing activity will be detectable (unstable flow curve on the ventilator, deflection in airway pressure during an expiratory pause). In this phase ("NMBA interruption") same clinical data will be collected as at baseline. Patients will be ventilated in the same ventilation mode as before (Volume Controlled mechanical ventilation), but the inspiratory trigger on the ventilator will be turned on to reduce patient-ventilator asynchronies. When an EIT trace lasting at least 10 minutes will be recorded, an NMBA bolus (as prescribed by the treating physician) will be administered and a continuous infusion will be restarted. Clinical data will be collected again in this phase ("NMBA restart").

NCT ID: NCT04995679 Completed - Clinical trials for Osteoarthritis, Knee

Residual Pain After Successful Implant of Metaphyseal Sleeves in Total Knee Arthroplasty

Start date: July 15, 2019
Phase: N/A
Study type: Interventional

: Total knee revision arthroplasty is increasing in daily practice and will become more relevant in the years to come. Bone loss is a significant challenge in total knee arthroplasty (TKA) especially in revision procedures. Metaphyseal sleeves are widely used to bypass bone loss and improve stability. This study aims to report the results of primary and revision TKA (R-TKA) using metaphyseal sleeves.

NCT ID: NCT04995380 Completed - Acute Cholecystitis Clinical Trials

Validation and Comparison of Scores for Prediction of RIsk for Post-operative Major Morbidity After Cholecystectomy in Acute Calculous Cholecystitis (SPRIMACC)

SPRIMACC
Start date: September 1, 2021
Phase:
Study type: Observational

The SPRIMACC study is a prospective multicenter observational study with the primary endpoint to prospectively validate the Chole-Risk score in predicting a complicated postoperative course (post-operative major complications (Clavien-Dindo>=3a), length of stay (LOS) > 10 days or need of readmission within 30 days from the discharge) in patients undergoing Early Cholecystectomy (EC) for Acute Calculous Cholecystitis (ACC). The secondary endpoints of the study are to prospectively validate and compare other wellknown risk prediction models (the POSSUM/P-POSSUM score, the Modified Frailty Index (mFI), the Charlson Comorbidity Index (CCI), the American Society of Anesthesiologists (ASA) score and the APACHE II score) in predicting a complicated post-operative course in patients undergoing EC.

NCT ID: NCT04995315 Completed - Clinical trials for Pyruvate Kinase Deficiency

Pyruvate Kinase Deficiency Global Longitudinal Registry Substudy of Protocol AG348-C-008

Start date: July 2, 2021
Phase:
Study type: Observational

This is a substudy of Study AG348-C-008, an observational, longitudinal, multicenter, global registry that aims to better understand the longitudinal clinical implications of pyruvate kinase deficiency (PK deficiency). The primary purpose of this study is to describe the cognition of participants with PK deficiency, as objectively measured by the Cogstate Brief Battery (CBB).

NCT ID: NCT04992325 Completed - Diabetes Mellitus Clinical Trials

AS-OCT Study in Diabetic Retinopathy

Start date: July 1, 2020
Phase:
Study type: Observational

This study evaluates the corneal features using anterior segment - optical coherence tomography in patients affected by type 2 diabetes mellitus